Population Health Sciences

You are here

Publications

Found 174 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is R  [Clear All Filters]
2019
Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al..  2019.  No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.
Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al..  2019.  No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.  2019.  A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.  2019.  A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Anderson MR, Tabah A, RoyChoudhury A, Lederer DJ.  2019.  Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study.. Ann Am Thorac Soc. 16(2):231-239.
Bhagwat P, Kapadia SN, Ribaudo HJ, Gulick RM, Currier JS.  2019.  Racial Disparities in Virologic Failure and Tolerability During First-Line HIV Antiretroviral Therapy.. Open Forum Infect Dis. 6(2):ofz022.
Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, Agarwal S, Sharma A, Zeana C, Zingman B et al..  2019.  A Randomized Placebo-Controlled Trial of Low- Versus Moderate-Dose Vitamin D3 Supplementation on Bone Mineral Density in Postmenopausal Women With HIV.. J Acquir Immune Defic Syndr. 80(3):342-349.
Behrendt C-A, Kölbel T, Debus ESebastian, Rieß HChristian, Sedrakyan A.  2019.  Reply.. J Vasc Surg. 69(4):1328.
Rosenkranz KM, Ballman K, McCall L, Kubicky CDai, Cuttino L, Le-Petross H, Hunt K, Giuliano A, Van Zee K, Haffty B et al..  2019.  Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report". Ann Surg Oncol. 26(2):702.
Da Cunha RJ, MacMahon A, Jones MT, Savenkov A, Deland J, Roberts M, Levine D, Elliot A, Kennedy J, Drakos M et al..  2019.  Return to Sports and Physical Activities After First Metatarsophalangeal Joint Arthrodesis in Young Patients.. Foot Ankle Int. 40(7):745-752.
Grossman LV, Creber RMMasterso, Ancker JS, Ryan B, Polubriaginof F, Qian M, Alarcon I, Restaino S, Bakken S, Hripcsak G et al..  2019.  Technology Access, Technical Assistance, and Disparities in Inpatient Portal Use.. Appl Clin Inform. 10(1):40-50.
Grossman LV, Creber RMMasterso, Ancker JS, Ryan B, Polubriaginof F, Qian M, Alarcon I, Restaino S, Bakken S, Hripcsak G et al..  2019.  Technology Access, Technical Assistance, and Disparities in Inpatient Portal Use.. Appl Clin Inform. 10(1):40-50.
Edwards TL, Giri A, Hellwege JN, Hartmann KE, Stewart EA, Jeff JM, Bray MJ, Pendergrass SA, Torstenson ES, Keaton JM et al..  2019.  A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids.. Front Genet. 10:511.
Creber RMasterson, Russell D, Dooley F, Jordan L, Baik D, Goyal P, Hummel S, Hummel EK, Bowles KH.  2019.  Use of the Palliative Performance Scale to estimate survival among home hospice patients with heart failure.. ESC Heart Fail. 6(2):371-378.
2018
Murphy SM, McCollister KE, Leff JA, Yang X, Jeng PJ, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR.  2018.  Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.. Ann Intern Med.
Ali SB, Romero J, Morrison K, Hafeez B, Ancker JS.  2018.  Focus Section Health IT Usability: Applying a Task-Technology Fit Model to Adapt an Electronic Patient Portal for Patient Work.. Appl Clin Inform. 9(1):174-184.
2017
Pesko MF, Robarts AMT.  2017.  Adolescent Tobacco Use in Urban Versus Rural Areas of the United States: The Influence of Tobacco Control Policy Environments.. J Adolesc Health. 61(1):70-76.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Li J, Dow WH, Rosero-Bixby L.  2017.  Education Gains Attributable to Fertility Decline: Patterns by Gender, Period, and Country in Latin America and Asia.. Demography. 54(4):1353-1373.
Goldberg EM, Trivedi AN, Mor V, Jung H-Y, Rahman M.  2017.  Favorable Risk Selection in Medicare Advantage: Trends in Mortality and Plan Exits Among Nursing Home Beneficiaries.. Med Care Res Rev. 74(6):736-749.